e purpose of this study is to develop and evaluate SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences), a family-centered program designed to support adolescents whose parent has been diagnosed with cancer. The study has two phases. In the first phase, parents and adolescents will participate in interviews or focus groups to help researchers understand their experiences and identify the types of support that families need. Information from these discussions will be used to refine the SHINE program. In the second phase, families will be randomly assigned to either receive the SHINE program or continue with their usual supportive care. The SHINE program consists of approximately four sessions delivered over 8 weeks and focuses on improving communication, coping skills, resilience, and emotional well-being. Adolescents will complete questionnaires before the program begins, immediately after the 8-week intervention period, and 3 months later. Researchers will evaluate whether SHINE is feasible to deliver, acceptable to families, and shows promise for improving psychosocial outcomes among adolescents coping with a parent's cancer diagnosis.
A parental cancer diagnosis can significantly affect the emotional and psychological well-being of children and adolescents. Youth experiencing parental cancer are at increased risk for anxiety, depression, stress, communication difficulties, and impaired coping. Despite these challenges, relatively few evidence-based psychosocial interventions have been developed specifically for this population, and many existing interventions have not incorporated input from adolescents and families during development. The SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences) study is a mixed-methods investigation designed to develop and pilot-test a family-centered psychosocial intervention for adolescents ages 10-17 whose parent has been diagnosed with Stage I-IV cancer. The study consists of two sequential phases. Aim 1 uses qualitative focus groups with parents and individual interviews with adolescents to identify priority psychosocial needs related to parental cancer, including age-appropriate information, family communication, coping strategies, peer support, emotional expression, and ongoing supportive care. Findings from these interviews will be used to refine the SHINE intervention, and a subset of families will participate in additional feedback sessions to finalize intervention materials. Aim 2 is a pilot randomized controlled trial enrolling approximately 40 families (one parent with cancer and one adolescent child per family). Following completion of baseline assessments, families will be randomized in a 1:1 ratio to either the SHINE intervention or usual supportive care. The SHINE intervention is a modular psychosocial program delivered over approximately 8 weeks through approximately four sessions that may be conducted in person or virtually using HIPAA-compliant platforms. Primary objectives are to evaluate the feasibility of recruitment, retention, and intervention adherence, as well as participant acceptability and satisfaction. Secondary objectives are to estimate the preliminary effects of SHINE on adolescent psychosocial outcomes, including illness perceptions, coping, resilience, stress, depression, anxiety, peer relationships, family functioning, and communication. Outcomes will be assessed at baseline, immediately following the intervention, and at 3-month follow-up using validated patient-reported outcome measures. The results of this pilot study will provide feasibility data and preliminary effect size estimates to support future fully powered clinical trials evaluating psychosocial interventions for families affected by parental cancer.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
80
The SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences) intervention is a family-centered, modular behavioral intervention designed to improve psychosocial outcomes among adolescents with a parent diagnosed with cancer. The intervention consists of approximately four sessions delivered over an 8-week period, either in person or remotely using HIPAA-compliant platforms. Intervention modules address age-appropriate cancer education, family communication, coping skills, resilience, peer support, and emotional well-being. Content is informed by qualitative input from adolescents, parents, and clinical providers and may be tailored to family needs while maintaining a standardized intervention framework.
Participants assigned to this group will receive the standard supportive care services routinely available through UT Southwestern Simmons Comprehensive Cancer Center. These services may include access to oncology social work, counseling, patient navigation, educational resources, and community support programs as clinically indicated. Participants will not receive the SHINE intervention during the study period but will complete the same study assessments as the intervention group.
UT Southwestern Simmons Comprehensive Cancer Center
Dallas, Texas, United States
Recruitment Rate
Recruitment rate will be defined as the percentage of eligible families who enroll in the study.
Time frame: From study initiation through completion of participant enrollment (approximately 36 months).
Retention Rate
Retention rate will be defined as the percentage of enrolled families who complete all planned study assessments through the 3-month follow-up.
Time frame: Baseline through 3-month follow-up.
Intervention Adherence Rate
Intervention adherence will be defined as the percentage of participants randomized to the SHINE intervention who complete all planned intervention sessions (approximately four sessions over 8 weeks).
Time frame: Baseline through completion of the 8-week intervention.
Participant Satisfaction and Acceptability Questionnaire Total Score
Acceptability will be assessed using a study-specific Participant Satisfaction and Acceptability Questionnaire administered immediately following completion of the SHINE intervention. The questionnaire consists of Likert-scale items assessing satisfaction, perceived usefulness, and willingness to recommend the intervention. Total scores range from 1 to 5, with higher scores indicating greater acceptability and satisfaction.
Time frame: Immediately following the 8-week intervention
Perceptions of Parental Illness Questionnaire for Cancer (PPIQ-C)
Perceptions of Parental Illness Questionnaire for Cancer (PPIQ-C) Coherence Subscale Score. The Coherence subscale measures adolescents' understanding of their parent's cancer. Scores range from 1 to 5, with higher scores indicating greater illness understanding.
Time frame: Baseline, 8 weeks, and 3 months
Communication Self-Efficacy Scale
Change in communication self-efficacy measured using the Communication Self-Efficacy Scale (CSES). Total scores range from 10 to 50. Higher scores indicate greater communication self-efficacy.
Time frame: Baseline, 8 weeks, and 3 months
Connor-Davidson Resilience Scale (CD-RISC-25) Total Score
Change in resilience measured using the Connor-Davidson Resilience Scale (CD-RISC-25). The Connor-Davidson Resilience Scale consists of 25 items with total scores ranging from 0 to 100. Higher scores indicate greater resilience.
Time frame: Baseline, 8 weeks, and 3 months
Perceived Stress Scale (PSS-10)
Change in stress measured using the Perceived Stress Scale (PSS-10). The Perceived Stress Scale (10-item) total score ranges from 0 to 40. Higher scores indicate greater perceived stress.
Time frame: Baseline, 8 weeks, and 3 months
Patient Health Questionnaire for Adolescents (PHQ-A)
Change in depressive symptoms measured using the Patient Health Questionnaire for Adolescents (PHQ-A). Total scores range from 0 to 27. Higher scores indicate more severe depressive symptoms.
Time frame: Baseline, 8 weeks, and 3 months
Generalized Anxiety Disorder 7-item Scale (GAD-7)
Change in anxiety measured using the Generalized Anxiety Disorder Scale (GAD-7). Total scores range from 0 to 21. Higher scores indicate more severe anxiety symptoms.
Time frame: Baseline, 8 weeks, and 3 months
PROMIS Pediatric Peer Relationships Short Form
Change in peer relationships measured using the PROMIS Pediatric Peer Relationships Short Form. Scores are converted to standardized T-scores (mean = 50; standard deviation = 10). Higher T-scores indicate better peer relationships.
Time frame: Baseline, 8 weeks, and 3 months
McMaster Family Assessment Device - General Functioning Subscale
Change in family functioning measured using the McMaster Family Assessment Device - General Functioning (FAD-GF). Mean scores range from 1.0 to 4.0. Higher scores indicate poorer family functioning.
Time frame: Baseline, 8 weeks, and 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.